-
-
-
-
Telephone management of anticoagulation treatment works; FDA wants to change rules to expand experimental drug availability; Aprotinin injection labeling revised; FDA warns of safety concern with rituximab; FDA approves novel device for brain damage in infants; Pfizer ends phase 3 torcetrapib/atorvastatin trial
-
Increased development of emergency department (ED) pharmacy services and increasing involvement of pharmacists in hospital EDs can contribute to improvements in ED shortcomings identified in a recent Institute of Medicine report on the future of emergency care in the U.S. health system.
-
The practice of pharmacy has changed significantly in recent years, and continues to evolve today, according to MLC Solutions principals Charlotte Kenreigh, PharmD, and Linda Timm Wagner, PharmD.
-
AHC Media appreciates the faith you have placed in us to provide you with practical, authoritative information. As a token of our gratitude for your support, we would like to provide you with the free white paper, The Joint Commission: What Hospitals Can Expect in 2007.
-
Matsumoto AK, Babul N, Ahdieh H. Oxymorphone ER tablets relieve moderate to severe pain and improve physical function is osteoarthritis: Results of a randomized, double-blind, placebo and active-controlled Phase III Trial. J Pain 2005; 6:357-366.
-
A survey of U.S. community hospitals that were part of a national group purchasing organization charged with identifying and characterizing pharmacy productivity monitoring systems found the systems often failed to capture all relevant clinical workload data.
-
FDA recently approved these drugs:
QLT USA's metronidiazole vaginal gel, 0.75%, the first generic version of 3M's MetroGel-Vaginal was approved for treating bacterial vaginosis.